Skip to content

Evaluation of T2, T3 Sympathectomy for Postmastectomy Pain Syndrome by Pulse Oximeter

Evaluation of T2, T3 Sympathectomy for Postmastectomy Pain Syndrome by Thermal Radiofrequency Versus Chemical Neurolysis Using Perfusion Index Derived Pulse Oximeter

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04953507
Enrollment
54
Registered
2021-07-08
Start date
2021-07-03
Completion date
2025-02-25
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia

Brief summary

The aim of the study is to compare the efficacy of T2, T3 sympathetic block using thermal radiofrequency versus chemical neurolysis in postmastectomy pain syndrome using perfusion index derived from pulse oximetry.

Detailed description

Postmastectomy pain is a chronic pain condition with neuropathic nature. Several drugs and methods are used for its management. This study was designed to compare the efficacy of both thermal radiofrequency and chemical neurolysis in management of postmastectomy pain through using perfusion index derived from pulse oximetry.

Interventions

Radiofrequency lesioning at level of T2 and T3 using 80°c for 120 seconds

injection of 1.5 ml of the chemical neurolytic agent (phenol in saline 8%) at each level

Sponsors

National Cancer Institute, Egypt
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Female patients with postmastectomy pain syndrome * ≥ Age 18 years * ASA II-III

Exclusion criteria

* patient refusal * coagulation defects * abnormal kidney or liver functions * local infection at site of injection * bone metastases * severe cardiorespiratory disease

Design outcomes

Primary

MeasureTime frameDescription
Visual analogue scoreup to 24 weeksminimum score 0 and maximum score 10

Secondary

MeasureTime frameDescription
Perfusion index trendprocedure timemeasuring the change in perfusion index in the ipsilateral limb after the procedure compared to pre-procedural
Opioid consumptionup to 24 weeksaverage opioid consumption

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026